Literature DB >> 14614359

Acquired hemophilia masked by warfarin therapy: report on two cases.

Bertil Uggla1, Olle Linder, Sam Schulman.   

Abstract

Spontaneous appearance of acquired anticoagulants is a rare phenomenon. We present two cases, where such antibodies against factor VIII were masked by warfarin therapy. The two patients were anticoagulated with warfarin due to mechanical heart valve and recurrent thromboembolic events, respectively. Different therapies against the inhibitor of factor VIII were used in the two cases. One patient received corticosteroids and high-dose gammaglobulin with temporary effect and was then effectively treated with cyclophosphamide. The other patient was successfully treated with cyclosporine. The special problems of keeping the balance between thrombosis and bleeding in this group of patients with need of anticoagulation due to mechanical heart valves or other thrombogenic factors are discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14614359     DOI: 10.1097/00001721-200312000-00014

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  3 in total

1.  Acquired inhibitors of clotting factors: AICE recommendations for diagnosis and management.

Authors:  Massimo Franchini; Giancarlo Castaman; Antonio Coppola; Cristina Santoro; Ezio Zanon; Giovanni Di Minno; Massimo Morfini; Elena Santagostino; Angiola Rocino
Journal:  Blood Transfus       Date:  2015-06-24       Impact factor: 3.443

2.  A 75-year-old woman with acquired haemophilia disguised by warfarin treatment.

Authors:  Sarah Lawless; Gary Benson
Journal:  BMJ Case Rep       Date:  2015-10-06

3.  Acquired Hemophilia A May Be Associated with Ticagrelor Therapy in a 52-Year-Old Man After a Recent Percutaneous Transluminal Coronary Angioplasty.

Authors:  Paola Pasquino; Roberto Canaparo; Tiziana Capello; Barbara Deorsola; Laura Perazzolo; Claudio Marengo; Loredana Serpe
Journal:  Clin Med Insights Case Rep       Date:  2016-09-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.